With strength, China's vaccines go everywhere

On the evening of August 10th, at Dhaka Airport in Bangladesh, more than 1.

Just a few hours later, in the early morning of August 11, more than 970,000 doses of vaccine arrived at Islamabad International Airport in Pakistan

Loading a freezer, taking a truck, transferring to a plane.

As of early August, China has donated vaccines to more than 100 countries and exported vaccines to more than 60 countries at the same time.

China's vaccines go all directions, and there is a long road.

Safe and effective, nearly 100 countries have access to Chinese vaccines

At the New Crown Vaccine Cooperative Enterprise Dialogue held on July 29, Yang Xiaoming, chief engineer of Sinopharm Group and chairman of China Biotech, introduced the broad scope of China's vaccines going global in his speech

He said that Sinopharm's China Bio-New Crown Vaccine has obtained the emergency use certification of the World Health Organization and the EU GMP certification, has been registered and marketed in 8 countries, and has been approved for emergency use or market access in 87 countries, regions and international organizations around the world

"Approved for emergency use or conditional listing in more than 50 countries, and entered the World Health Organization's emergency use list

On August 16, Sinopharm updated its data again: the new crown vaccine was registered and marketed in 9 countries, and was approved for use in 98 countries, regions and international organizations around the world.

The data updates time after time have demonstrated the vigorous pace of China's vaccines going global

China's vaccines are going everywhere and are gaining the trust of more countries, and they are also helping people in more countries build immunization lines

China's vaccines go everywhere, relying on excellent "stepping stones" and real performance in the fight against the epidemic

Vaccines are medicines and are a special kind of commodity.

The “stepping stone” for landing is very strict, but also very simple, that is, to provide evidence that proves effective and safe

The most stringent of all certifications is undoubtedly the certification of the World Health Organization

According to the person in charge of Sinopharm's China Biotechnology, the WHO has very strict requirements on the certification materials used in emergency.

Relying on the excellent strength demonstrated by the data and information, the WHO announced on May 7 and June 1 that Sinopharm Zhongsheng vaccine and Kexing vaccine had obtained emergency use certification
.

Going everywhere, China's vaccines can withstand professional "review"

As the saying goes, the insider sees the doorway
.
The Chinese vaccine has been and is undergoing professional "review" by immunization experts from all over the world
.

On July 20, Sri Jayawardenepura University, a well-known university in Sri Lanka, officially released its research report on the effectiveness of the Sinopharm China Bio-New Crown Inactivated Vaccine
.
The results of the study show that Sinopharm's China Bio-New Crown Vaccine is very effective against the Delta strain of the new crown mutant strain
.

On July 8th, the Turkish research team published the results of the study on China's Kexing vaccine
.
According to the data, the study was jointly carried out by more than 20 institutions and universities (clinical research centers), which shows that countries are rigorous and rigorous in "understanding" the safety and effectiveness of vaccines
.
Through the follow-up and analysis of more than 11,000 subjects, the study shows that the protective efficacy of China Kexing vaccine is 83.
5%, and the effective rate of preventing severe illness and death is 100%
.

Argentina also specifically studied the protective effects of Chinese biological vaccines on elderly people over 60 years of age
.
On June 30, the Argentine Ministry of Health released a report showing that the overall mortality protection rate of people over 60 years of age was 84% ​​by inoculation of two doses of Chinese biological vaccines
.

There are numerous similar studies.
In Peru, Brazil, Indonesia and many other countries, researchers have conducted sufficient research on the safety and effectiveness of Chinese vaccines.
Numerous results have shown that the Chinese new crown inactivated vaccine is safe and effective
.

Fulfill the promise: teach people how to fish, and also teach people how to fish

According to the latest report from Thai media, among the 23 million doses of COVID-19 vaccines in Thailand, the most vaccinated vaccine is China's Kexing COVID-19 vaccine, with more than 11 million people being vaccinated
.

Like Thailand, many countries are mainly vaccinated against China
.
In Victoria Falls, Zimbabwe, residents were vaccinated on a large scale with Sinopharm’s China Biotech Covid-19 vaccine.
The city became the first city in Zimbabwe to achieve herd immunity.
Since then, there has not been a single death case
.

With the development of the epidemic situation and the increase in demand for vaccines, the Chinese vaccine production and R&D team has launched a cooperation model with various countries, so that the locals can also obtain vaccine production capacity, not only to teach people to fish, but also to teach people to fish
.

On August 16, Sinopharm and Bangladesh reached a cooperation to jointly produce the new crown inactivated vaccine, which means that Bangladesh can carry out the semi-finished product of the new crown inactivated vaccine in China
.
Every month in the future, there will be at least 5 million doses of the new crown vaccine produced locally by themselves for local epidemic prevention and control
.

Kexing has signed nearly 900 million vaccine cooperation agreements with 20 countries outside of China this year
.
Yin Weidong said that these vaccines are not only produced in China, but also produced by the Butantan Institute in Indonesia and Brazil, as well as partners in Turkey, Malaysia, and Egypt
.

Fulfilling its commitments, China has taken the lead in cooperating with developing countries in vaccine production.
Up to now, the UAE, Egypt, Indonesia, and Brazil have become the first countries with new crown vaccine production capacity
.